The maker of Viagra, Lipitor and Advil has been slashing thousands of jobs since acquiring rival Wyeth in 2009.
Now, as several of its key products run out of patent protection, it is also downsizing its research and development spending.
The company plans to still cut another 5,530 employees -- or 5% of its global workforce. While many of those jobs cuts will come from the closure of a factory in Sandwich, England, they will also affect many U.S. employees who work in R&D roles.
These young job seekers graduated into the worst labor market since the Great Depression.
|SpaceX to fly two space tourists around the moon in 2018|
|Company that owns Kay and Jared jewelry chains hit with allegations of rampant discrimination|
|Former FCC chairman: Things are 'going the way I feared'|
|First-time homebuyer? Avoid these states|
|Stuffed toys leak millions of voice recordings from kids and parents|